{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:06:37Z","timestamp":1790431597356,"version":"4.1.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.vaccine.2006.12.013","type":"journal-article","created":{"date-parts":[[2006,12,22]],"date-time":"2006-12-22T22:35:23Z","timestamp":1166826923000},"page":"2811-2816","source":"Crossref","is-referenced-by-count":15,"title":["The rise in pertussis cases urges replacement of chemically-inactivated with genetically-inactivated toxoid for DTP"],"prefix":"10.1016","volume":"25","author":[{"given":"John B.","family":"Robbins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Schneerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry M.","family":"Keith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Shiloach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birger","family":"Trollors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.12.013_bib1","unstructured":"Centers for Disease Control and Prevention. Summary of notifiable diseases, United States, 2004. MMWR 2006;53(53):1\u201379 [published June 16, 2006]."},{"key":"10.1016\/j.vaccine.2006.12.013_bib2","first-page":"308","article-title":"The re-emergence of pertussis in Israel","volume":"8","author":"Moerman","year":"2006","journal-title":"Israel J Med Sci"},{"key":"10.1016\/j.vaccine.2006.12.013_bib3","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/S0140-6736(96)05243-9","article-title":"A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned","volume":"348","author":"Taranger","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.12.013_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.4049\/jimmunol.54.4.325","article-title":"Circulating antitoxin at the onset of diphtheria in 425 patients","volume":"54","author":"Ipsen","year":"1946","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.12.013_bib5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1086\/322639","article-title":"Mass vaccination of children with pertussis toxoid\u2014decreased incidence in both vaccinated and nonvaccinated persons","volume":"33","author":"Taranger","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.013_bib6","first-page":"731","article-title":"Le Microbe De La Coqueluche","volume":"20","author":"Bordet","year":"1906","journal-title":"Ann Inst Pasteur"},{"key":"10.1016\/j.vaccine.2006.12.013_bib7","first-page":"296","article-title":"The epidemiology of pertussis","volume":"12","author":"Luttinger","year":"1916","journal-title":"Am J DIs Child"},{"key":"10.1016\/j.vaccine.2006.12.013_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bmj.295.6601.751","article-title":"From whom do children catch pertussis?","volume":"295","author":"Thomas","year":"1987","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2006.12.013_bib9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2105\/AJPH.25.2.147","article-title":"Significance of bacteriological methods in the diagnosis and control of whooping cough","volume":"25","author":"Kendrick","year":"1935","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.vaccine.2006.12.013_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.1933.02740280007003","article-title":"Vaccination against whooping cough","volume":"101","author":"Madsen","year":"1933","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.12.013_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/jama.1933.02740040007003","article-title":"Whooping cough: a study in immunization","volume":"100","author":"Sauer","year":"1933","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.12.013_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2105\/AJPH.37.7.803-b","article-title":"Mouse protection tests in the study of pertussis vaccine; a comparative series using the intracerebral route for challenge","volume":"37","author":"Kendrick","year":"1947","journal-title":"Am J Publ Health"},{"key":"10.1016\/j.vaccine.2006.12.013_bib13","first-page":"234","article-title":"Pertussis and pertussis vaccine control","volume":"46","author":"Pittman","year":"1956","journal-title":"J Wash Acad Sci"},{"key":"10.1016\/j.vaccine.2006.12.013_bib14","first-page":"454","article-title":"Vaccination against whooping cough. Relation between protection tests in children and results of laboratory tests","volume":"2","author":"Medical Research Council","year":"1956","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2006.12.013_bib15","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/IAI.46.2.422-428.1984","article-title":"Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections","volume":"46","author":"Sato","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.12.013_bib16","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/path.1700920213","article-title":"An immunofluorescence study of the action of antibody in experimental intracerebral infection of mice with Bordetella pertussis","volume":"92","author":"Iida","year":"1966","journal-title":"J Path Bact"},{"key":"10.1016\/j.vaccine.2006.12.013_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1128\/JB.66.2.166-169.1953","article-title":"Antigenic relationships of Haemophilus pertussis, the parapertussis bacillus, and Brucella bronchiseptica as shown by cross protection tests in mice","volume":"66","author":"Kendrick","year":"1953","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2006.12.013_bib18","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1348-0421.1982.tb00243.x","article-title":"Comparison of biological activities of Bordetella pertussis mutants lacking the ability to produce filamentous hemagglutinin with similar activities of other smooth strains","volume":"26","author":"Watanabe","year":"1982","journal-title":"Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2006.12.013_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/infdis\/144.2.187","article-title":"Pertussis in the United States. A look at vaccine efficacy","volume":"144","author":"Broome","year":"1981","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.013_bib20","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1001\/jama.267.20.2745","article-title":"Efficacy of whole-cell pertussis vaccine in preschool children in the United States","volume":"267","author":"Onorato","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.12.013_bib21","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1136\/bmj.282.6280.1925","article-title":"Effect of vaccination on severity and dissemination of whooping cough","volume":"282","author":"Grob","year":"1981","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2006.12.013_bib22","unstructured":"Public Health Service Research Laboratory and 21 health authorities. Efficacy of pertussis vaccination in England. Br Med J 1982;285:357\u20139."},{"key":"10.1016\/j.vaccine.2006.12.013_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2307\/4592424","article-title":"Epidemiology of a small pertussis outbreak in Kent County, Michigan","volume":"80","author":"Lambert","year":"1965","journal-title":"Public Heath Rep"},{"key":"10.1016\/j.vaccine.2006.12.013_bib24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/bmj.296.6622.612","article-title":"Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study","volume":"296","author":"Jenkinson","year":"1988","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2006.12.013_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1017\/S0950268805003833","article-title":"Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis","volume":"133","author":"Versteegh","year":"2005","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2006.12.013_bib26","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0264-410X(03)00007-0","article-title":"Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness","volume":"21","author":"Pr\u00e9ziosi","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.013_bib27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0140-6736(75)90907-1","article-title":"Use of pertussis vaccine in an epidemic involving hospital staff","volume":"2","author":"Linnenman","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.12.013_bib28","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/clinids\/1.3.401","article-title":"Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis","volume":"1","author":"Pittman","year":"1979","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.013_bib29","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/IAI.55.3.497-501.1987","article-title":"Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis","volume":"55","author":"Marchitto","year":"1987","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.12.013_bib30","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1128\/jb.169.6.2847-2853.1987","article-title":"Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes","volume":"169","author":"Arico","year":"1987","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2006.12.013_bib31","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1146\/annurev.mi.40.100186.003305","article-title":"Virulence factors of Bordetella pertussis","volume":"40","author":"Weiss","year":"1986","journal-title":"Ann Rev Microbiol"},{"key":"10.1016\/j.vaccine.2006.12.013_bib32","series-title":"Mechanisms of lymphocyte activation and immune regulation VII","first-page":"207","article-title":"Immunity to pertussis: not all virulence factors are protective antigens","author":"Robbins","year":"1998"},{"key":"10.1016\/j.vaccine.2006.12.013_bib33","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/IAI.45.3.718-725.1984","article-title":"In-vitro inhibition of murine macrophage migration by Bordetella pertussis lymphocytosis-promoting factor","volume":"45","author":"Meade","year":"1984","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.12.013_bib34","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4049\/jimmunol.135.6.4135","article-title":"Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin","volume":"135","author":"Spangrude","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2006.12.013_bib35","first-page":"955","article-title":"Placebo-controlled trial of two acellular pertussis vaccines in Sweden-Protective efficacy and adverse events","volume":"i","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.12.013_bib36","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1001\/archpedi.1991.02160110077024","article-title":"Acellular pertussis vaccines: efficacy and evaluation of clinical case definitions","volume":"145","author":"Blackwelder","year":"1991","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2006.12.013_bib37","unstructured":"WHO Criteria for Diagnosis of Pertussis\u20141991. WHO Meeting on case definitions of pertussis. Geneva: World Health Organization; 1991. p. 10\u20131 [MIM\/EPI\/PERT\/91.1]."},{"key":"10.1016\/j.vaccine.2006.12.013_bib38","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0140-6736(97)06508-2","article-title":"Randomized controlled trial of two-component, three-component, and five component acellular pertussis vaccines compared with whole-cell pertussis vaccine","volume":"350","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.12.013_bib39","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1056\/NEJMoa050824","article-title":"Efficacy of acellular pertussis vaccine among adolescents and adults","volume":"353","year":"2005","journal-title":"N Eng J Med"},{"key":"10.1016\/j.vaccine.2006.12.013_bib40","first-page":"25","article-title":"Case definitions of infectious conditions under public health surveillance","volume":"46","author":"Centers for Disease Control","year":"1997","journal-title":"MMWR"},{"key":"10.1016\/j.vaccine.2006.12.013_bib41","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1469-0691.1999.tb00520.x","article-title":"Aquisition of serum antibodies unrelated to Bordetella pertussis infection","volume":"5","author":"Carlsson","year":"1999","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2006.12.013_bib42","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/CDLI.5.2.130-134.1998","article-title":"Evaluation of an immunoglobulin G enzyme-linked immunosorbent assay for pertussis toxin and filamentous hemagglutinin in diagnosis of pertussis in Senegal","volume":"5","author":"Simondon","year":"1998","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.12.013_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/PL00015016","article-title":"Evaluation of a single-sample serological technique for diagnosing pertussis in unvacccinated children","volume":"18","author":"von Konig","year":"1999","journal-title":"Eur J Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.013_bib44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00006454-199811000-00013","article-title":"Safety and immunogenicity of a combined diphtheria-tetanus-acellular pertussis-inactivated polio vaccine-Haemophilus influenzae type b vaccine administered at 2-4-6-13 or 3-5-12 months of age","volume":"17","author":"Carlsson","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.12.013_bib45","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1016\/S0264-410X(03)00407-9","article-title":"Low level of antipertussis antibodies plus lack of history correlate with susceptibility after household exposure to Bordetella pertussis","volume":"21","author":"Storsaeter","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.013_bib46","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1128\/CDLI.11.6.1045-1053.2004","article-title":"Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis, filamentous hemagglutinin and fimbriae in adolescents and adults from the United States","volume":"11","author":"Baughman","year":"2004","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.vaccine.2006.12.013_bib47","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1128\/CVI.13.3.341-348.2006","article-title":"Characterization of serological responses to pertussis","volume":"13","author":"Watanabe","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2006.12.013_bib48","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis toxoid vaccine","volume":"333","author":"Trollfors","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2006.12.013_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1086\/426454","article-title":"The diphtheria and pertussis components of DTP should be genetically-inactivated mutant toxins","volume":"191","author":"Robbins","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.013_bib50","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1086\/315318","article-title":"Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis","volume":"181","author":"Taranger","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.013_bib51","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00006454-199803000-00005","article-title":"Immunization of children with pertussis toxoid decreases spread of pertussis within the family","volume":"17","author":"Trollfors","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.12.013_bib52","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1016\/j.vaccine.2004.03.046","article-title":"Impact of routine vaccination with a pertussis vaccine in Denmark","volume":"22","author":"Hviid","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.013_bib53","first-page":"1258","article-title":"Pertussis toxin gene: nucleotide sequence and genetic organisation","volume":"232","author":"Locht","year":"1986","journal-title":"Science (USA)"},{"key":"10.1016\/j.vaccine.2006.12.013_bib54","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1073\/pnas.83.13.4631","article-title":"Cloning and sequence of the pertussis toxin genes: operon structure and gene duplication","volume":"83","author":"Nicosia","year":"1986","journal-title":"Proc Natl Acad Sci (USA)"},{"key":"10.1016\/j.vaccine.2006.12.013_bib55","first-page":"72","article-title":"Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope","volume":"242","author":"Burnette","year":"1988","journal-title":"Science (USA)"},{"key":"10.1016\/j.vaccine.2006.12.013_bib56","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.2683073","article-title":"Mutants of pertussis toxin suitable for vaccine development","volume":"246","author":"Pizza","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2006.12.013_bib57","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/IAI.59.2.625-630.1991","article-title":"Properties of the pertussis toxin mutant PT-9K\/129G after formaldehyde treatment","volume":"59","author":"Nencioni","year":"1990","journal-title":"Infec Immun"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2006.12.013_bib58","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1542\/peds.96.3.548","article-title":"Comparison of 12 acellular pertussis vaccines: overview and serologic response","volume":"96","author":"Edwards","year":"1995","journal-title":"Pediatr"},{"key":"10.1016\/j.vaccine.2006.12.013_bib59","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.100.5.772","article-title":"A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15\u201320-month-old children","volume":"100","author":"Pichichero","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2006.12.013_bib60","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0264-410X(98)00040-1","article-title":"Persistance of protection through 33 months of age provide by immunization in infancy with to three component acellular pertussis vaccines. Stage II Working Group","volume":"16","author":"Salmasso","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.013_bib61","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/314869","article-title":"A randomized clinical trial of acellularr pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster development","volume":"180","author":"Keitel","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.013_bib62","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.vaccine.2005.11.024","article-title":"Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population","volume":"34","author":"Knuf","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.12.013_bib63","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archpedi.1978.02120290043006","article-title":"The changing epidemiology of pertussis in young infants: the role of adults as reservoirs of infection","volume":"132","author":"Nelson","year":"1978","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.vaccine.2006.12.013_bib64","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev.me.28.020177.001143","article-title":"Pertussis in the adult","volume":"28","author":"Linnemann","year":"1977","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.vaccine.2006.12.013_bib65","first-page":"959","article-title":"Infant pertussis, who was the source?","volume":"23","author":"Bisnard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2006.12.013_bib66","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(97)04334-1","article-title":"Impact of anti-vaccine movements on pertussis control: the untold story","volume":"351","author":"Gangarosa","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2006.12.013_bib67","first-page":"893","article-title":"Early infantile pertussis: increasingly prevalent and potentially fatal","volume":"159","author":"Smith","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2006.12.013_bib68","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1001\/jama.284.24.3145","article-title":"Individual and community risks of measles and pertussis associated with personal exemptions to immunization","volume":"284","author":"Feikin","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.12.013_bib69","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1001\/jama.275.21.1672","article-title":"Prevalence and incidence of adult pertussis in an urban population","volume":"275","author":"Nennig","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2006.12.013_bib70","first-page":"1650","article-title":"Population-based incidence of pertussis among adolescents and adults, Minnesota 1995\u20131996","volume":"171","author":"Strebel","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.013_bib71","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1542\/peds.113.4.733","article-title":"Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who received dexamethesone for chronic lung disease","volume":"113","author":"Robinson","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2006.12.013_bib72","doi-asserted-by":"crossref","first-page":"5383","DOI":"10.1128\/IAI.72.9.5383-5391.2004","article-title":"Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with vaccine containing acellular pertussis components","volume":"72","author":"Dagan","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2006.12.013_bib73","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2105\/AJPH.2004.053413","article-title":"Effect of a national vaccine shortage on vaccine coverage for American Alaska native children","volume":"96","author":"Groom","year":"2006","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2006.12.013_bib74","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/infdis\/132.6.707","article-title":"Can whooping cough be eradicated?","volume":"132","author":"Kendrick","year":"1975","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0601365X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0601365X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,10]],"date-time":"2023-05-10T06:14:31Z","timestamp":1683699271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0601365X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":74,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0264410X0601365X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.12.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}